Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1089131.RAr6DQItVfCHZ47ir5h6D9NtsdUtf-qRNBHK9sXZ_raX4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1089131.RAr6DQItVfCHZ47ir5h6D9NtsdUtf-qRNBHK9sXZ_raX4130_assertion type Assertion NP1089131.RAr6DQItVfCHZ47ir5h6D9NtsdUtf-qRNBHK9sXZ_raX4130_head.
- NP1089131.RAr6DQItVfCHZ47ir5h6D9NtsdUtf-qRNBHK9sXZ_raX4130_assertion description "[These results offer general import beyond prostate cancer, given that nuclear FHL2 is characteristic of other human cancers where oncogenic transcription factors that drive disease are activated like the AR in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1089131.RAr6DQItVfCHZ47ir5h6D9NtsdUtf-qRNBHK9sXZ_raX4130_provenance.
- NP1089131.RAr6DQItVfCHZ47ir5h6D9NtsdUtf-qRNBHK9sXZ_raX4130_assertion evidence source_evidence_literature NP1089131.RAr6DQItVfCHZ47ir5h6D9NtsdUtf-qRNBHK9sXZ_raX4130_provenance.
- NP1089131.RAr6DQItVfCHZ47ir5h6D9NtsdUtf-qRNBHK9sXZ_raX4130_assertion SIO_000772 23801747 NP1089131.RAr6DQItVfCHZ47ir5h6D9NtsdUtf-qRNBHK9sXZ_raX4130_provenance.
- NP1089131.RAr6DQItVfCHZ47ir5h6D9NtsdUtf-qRNBHK9sXZ_raX4130_assertion wasDerivedFrom befree-2016 NP1089131.RAr6DQItVfCHZ47ir5h6D9NtsdUtf-qRNBHK9sXZ_raX4130_provenance.
- NP1089131.RAr6DQItVfCHZ47ir5h6D9NtsdUtf-qRNBHK9sXZ_raX4130_assertion wasGeneratedBy ECO_0000203 NP1089131.RAr6DQItVfCHZ47ir5h6D9NtsdUtf-qRNBHK9sXZ_raX4130_provenance.